The United States spends more on health care as a share of the economy than most other high-income countries — yet  life expectancy is lower and suicide rates are higher than many of its peers. Austin’s Top Stock for September is focused on turning those trends around.

[vc_cta h2=”Empowering you to invest in your future!” h4=”Subscribe to 7investing to get direct access to Austin’s report.”][su_list icon=”icon: line-chart” icon_color=”#84c136″]

[/su_list]

Sign up today!

[/vc_cta]

Transcript

Here in the U.S., we spend more on health care as a share of the economy than most other high-income countries — yet we have lower life expectancies and higher suicide rates than many of our “peer” countries. My stock recommendation this month is focused on turning those trends around.

I’m 7investing Lead Advisor Austin Lieberman. Here at 7investing, our team finds our best 7 ideas in the stock market every month and provides them to our subscribers for just $17.

The company I’m recommending this month has spent nearly 20 years developing an innovative approach to help increase access to healthcare while lowering costs and improving outcomes. As unfortunate as the COVID-19 pandemic has been, it appears to have been a tipping point to nudge our healthcare system and regulators to accept a new paradigm of medical treatment and my company stands to benefit greatly from this generational opportunity.

Although my company has been around for almost two decades, there’s a lot of growth opportunity ahead. They’ve only recently entered into the fast-growing mental health and chronic condition markets. Additionally, less than 20% of their revenue comes from outside of the United States so there’s tremendous international growth potential as well.

To see the name of the company I’m recommending and get access to my full report, click the link below this video to start your subscription with 7investing.com.

We’re here to empower you to invest in your future. We are 7investing.